Publications
Increased incidence of forced admissions in Belgium and the Netherlands? An epidemiological approach KU Leuven
Uncharted territory of the epidemiological burden of cutaneous leishmaniasis in sub-Saharan Africa; a systematic review Institute of Tropical Medicine
INTRODUCTION: Cutaneous leishmaniasis (CL) is the most frequent form of leishmaniasis, with 0.7 to 1.2 million cases per year globally. However, the burden of CL is poorly documented in some regions. We carried out this review to synthesize knowledge on the epidemiological burden of CL in sub-Saharan Africa.
METHODS: We systematically searched PubMed, CABI Global health, Africa Index Medicus databases for publications on CL and its ...
Risk management of QTc-prolongation in patients receiving haloperidol: an epidemiological study in a University hospital in Belgium KU Leuven
An Epidemiological Reappraisal of the Familial Aggregation of Prostate Cancer: A Meta-Analysis Hasselt University KU Leuven
Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care University of Antwerp
Palliative Care Service Use in Four European Countries: A Cross-National Retrospective Study via Representative Networks of General Practitioners Vrije Universiteit Brussel Ghent University
Genome-wide association study reveals genetic markers for antimicrobial resistance in Mycoplasma bovis Ghent University
Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries Institute of Tropical Medicine
BACKGROUND: European travellers to endemic countries are at risk of malaria and may be affected by a different range of co-morbidities than natives of endemic regions. The safety profile, especially cardiac issues, of artenimol (previously dihydroartemisinin)-piperaquine (APQ) Eurartesim® during treatment of uncomplicated imported falciparum malaria is not adequately described due to the lack of longitudinal studies in this population. The ...
Overcoming publication and dissemination bias in infectious diseases clinical trials Institute of Tropical Medicine
Non-timely reporting, selective reporting, or non-reporting of clinical trial results are prevalent and serious issues. WHO mandates that summary results be available in registries within 12 months of study completion and published in full text within 24 months. However, only a limited number of clinical trials in infectious diseases, including those done during the COVID-19 pandemic, have their results posted on ClinicalTrials.gov. An ...